Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 2 |
2016 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
N Engl J Med. 2024 Feb 29;390(9):783-794. doi: 10.1056/NEJMoa2312100. Epub 2024 Feb 21.
N Engl J Med. 2024.
PMID: 38381664
Clinical Trial.
[Low mean cell hemoglobin is a reliable marker for iron deficiency screening].
Kellner SV, Kellner Á, Haragh A, Dombi P, Karádi É, Rajnics P, Kollár B, Alizadeh H, Ghosh M, Liposits A, Moizs M, Egyed M.
Kellner SV, et al. Among authors: haragh a.
Orv Hetil. 2016 Jan 3;157(1):35-8. doi: 10.1556/650.2016.30328.
Orv Hetil. 2016.
PMID: 26708685
Hungarian.
Item in Clipboard
[IL28B CC genotype: a protective factor and predictor of the response to interferon treatment in chronic hepatitis C virus infection].
Pár A, Pár G, Tornai I, Szalay F, Várszegi D, Fráter E, Papp M, Lengyel G, Fehér J, Varga M, Gervain J, Schuller J, Nemes Z, Péterfi Z, Tusnádi A, Hunyady B, Haragh A, Szinku Z, Pálinkás L, Berki T, Vincze A, Kisfali P, Melegh B.
Pár A, et al. Among authors: haragh a.
Orv Hetil. 2013 Aug 11;154(32):1261-8. doi: 10.1556/OH.2013.29680.
Orv Hetil. 2013.
PMID: 23916907
Hungarian.
Item in Clipboard
IL28B and IL10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort.
Pár A, Pár G, Tornai I, Szalay F, Várszegi D, Fráter E, Papp M, Lengyel G, Fehér J, Varga M, Gervain J, Schuller J, Nemes Z, Péterfi Z, Tusnádi A, Hunyady B, Haragh A, Szinku Z, Vincze A, Szereday L, Kisfali P, Melegh B.
Pár A, et al. Among authors: haragh a.
BMC Res Notes. 2014 Jan 8;7:12. doi: 10.1186/1756-0500-7-12.
BMC Res Notes. 2014.
PMID: 24398031
Free PMC article.
Item in Clipboard
Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis.
Maasoumy B, Hunyady B, Calvaruso V, Makara M, Vermehren J, Haragh A, Susser S, Bremer B, Cloherty G, Manns MP, Craxì A, Wedemeyer H, Sarrazin C.
Maasoumy B, et al. Among authors: haragh a.
PLoS One. 2014 Nov 12;9(11):e110857. doi: 10.1371/journal.pone.0110857. eCollection 2014.
PLoS One. 2014.
PMID: 25389779
Free PMC article.
Item in Clipboard
[Efficacy and safety of boceprevir based triple therapy in Hungarian patients with hepatitis C genotype 1 infection, advanced stage fibrosis and prior treatment failure].
Hunyady B, Abonyi M, Csefkó K, Gervain J, Haragh A, Horváth G, Jancsik V, Makkai E, Müller Z, Ribiczey P, Sipos B, Szabó O, Szalay F, Szentgyörgyi L, Tornai I, Újhelyi E, Varga M, Weisz G, Makara M.
Hunyady B, et al. Among authors: haragh a.
Orv Hetil. 2016 Aug;157(34):1366-74. doi: 10.1556/650.2016.30538.
Orv Hetil. 2016.
PMID: 27546804
Hungarian.
Item in Clipboard
Cite
Cite